Barry Constantine, founder of Resorbable Orthopedics LLC, said, "The patents offer innovative, safe and effective resorbable orthopedic products. The bone wax and delivery system address issues such as 'bone wax granuloma' and the delivery of materials that manage bone wound healing in a cost effective manner. At a time when there is a great need for safer and more affordable health care products, these are well timed solutions."

The Resorbable Orthopedics products covered by patents are:

A resorbable orthopedic hemostat (resorbable bone wax) used to stop blood flow. The U.S. market potential for this product is approximately $10 million. A delivery system for osteogenic/osteoinductive orthopedic products (bone void fillers). The market potential for bone void fillers has been estimated at $1.4 billion The company's patents also cover the formula as a delivery system for bone growth factors.

SOURCE Wound Management Technologies, Inc.